March 2024 - Page 8 of 18

WednesdayMar 20, 2024 9:00 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils New E-Boat Model, Names New CFO in Preparation for Industry Growth

The global electric boats market is forecast to more than double in size, increasing from $3.3 billion in 2023 to $7.7 billion by 2030 Vision Marine’s unveiling of its newest e-boat offering, the Phantom, couldn’t have come at more opportune time The company’s new chief financial officer brings invaluable expertise and insight in manufacturing, production and delivery As the electric boat sector is projected to double in value in the next few years, companies operating in the industry are positioning themselves to meet — and even exceed — the expectations this growth could create. For example, Vision Marine Technologies (NASDAQ:…

TuesdayMar 19, 2024 3:22 pm

QualityStocksNewsBreaks – SOBR Safe Inc.’s (NASDAQ: SOBR) Alcohol Detection Technology Poised to Improve Workplace Safety and Behavioral Outcomes

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”) has developed a patent-pending alcohol detection device to detect alcohol in humans with just a single touch of the finger. “SOBRsafe’s alcohol detection technology can improve workplace safety and provide advanced screening and monitoring solutions for the behavioral health industry… SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol through the user’s skin. No breath, blood or urine samples are required – making it a hygienic alternative to traditional breathalyzers,” a recent article reads. “SOBRsafe’s technology is integrated within the company’s robust and scalable platform, producing statistical and measurable user and business…

TuesdayMar 19, 2024 2:49 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Expanding Operations Within Agricultural Sectors

SenesTech (NASDAQ: SNES), a rodent pest control enterprise, has begun to establish a global reach for its innovative Birth Control for Rats(TM) products. “The company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects on food markets. On Jan. 29, SenesTech announced the signing of a distribution agreement with Poppe Enterprises LLC for the grain management market. Poppe Enterprises will be a stocking distributor for SenesTech’s Evolve(TM) soft bait in the outlets it serves in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado, according to the announcement… SenesTech’s Evolve(TM) soft bait delivers…

TuesdayMar 19, 2024 12:26 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 1,542,112 shares of common stock at a combined offering price of $4.215 per share of common stock (or per prefunded warrant in lieu thereof) and accompanying warrant, in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $4.09 per…

TuesdayMar 19, 2024 12:06 pm

QualityStocksNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in ‘First in Human’ Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, was featured in a recent episode of First in Human, a biotech-focused podcast featuring interviews with industry leaders and investors to learn about their journeys to in-human clinical trials. Hosted by Vial EVP Rich McCormick, the podcast is available for on-demand listening on First in Human by Vial. Rob Etherington, president, director and CEO of Clene joined the program to highlight information about the company’s work in the field of nanotechnology. “For decades…the idea of a therapeutic elemental metal having some medicinal efficacy has been well understood. We at Clene had the…

TuesdayMar 19, 2024 10:30 am

Correlate Energy Corp. (CIPI) Targets the U.S. Zero Operating Emissions Market

Correlate Energy, a publicly traded distributed energy solutions company, has positioned itself as the go-to company given the federal government’s push for greener buildings The government’s proposed definition of zero operating emissions buildings, seeks consistency with a framework for long-term goal-setting Correlate understands these changing tides and, through its three-pronged strategy, offers building owners and management the most technologically efficient and cost-effective ways to go green Correlate Energy (OTCQB: CIPI), a publicly traded company positioned to capitalize on America’s move toward efficient energy sourcing and use, is aware of the growing pressure for buildings to become more energy efficient. This…

TuesdayMar 19, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Closes Multiple Global Distribution Deals; Eyes 2024 as its Best Year Yet

SenesTech, a rapidly growing company specializing in highly effective fertility control solutions for animal pests, recently announced multiple product distribution deals outside the U.S. In Europe, it entered into an agreement with Q-chem, a pest control product supplier in The Netherlands In Australia, SenesTech entered into an agreement with Evicom, an environmental management firm with distribution in the country, as well as in New Zealand and the surrounding region In Asia, the company partnered with Agro Technic PTE Ltd, a pest control product manufacturer and distributor headquartered in Singapore SenesTech (NASDAQ: SNES), a rodent fertility control solutions provider, and the…

TuesdayMar 19, 2024 9:00 am

3rd BioPharma Supply Chain & Logistics Nexus Conference to Address Supply Chain and Logistics Issues in Biopharmaceutical Industry

Directors, managers, VPs, regulatory affairs personnel, and service providers of the logistics and operations verticals for the biopharma supply chain across Europe and North America are invited to attend the 3rd BioPharma Supply Chain & Logistics Nexus Conference being held April 25-26, 2024, at the Basel Mariott Hotel, Switzerland. The event aims to address critical issues and challenges in the supply chain and logistics within the biopharmaceutical industry. The event is hosted by BioPharma Nexus, a premier company organizing prestigious conferences aiming to foster networking and business ties between pharmaceutical and biotech companies and their service providers. The focus lies…

MondayMar 18, 2024 11:45 am

QualityStocksNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q4, FY 2023 Earnings Call

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, plans to release its financial results for the fourth quarter and fiscal year 2023 for the period ended Dec. 31, 2023 before market open on March 28, 2024. In addition, the company has scheduled a conference call that same day to discuss the financial report along with the company outlook; the call is scheduled to begin at 8 a.m. ET. D-Wave CEO Dr. Alan Baratz and CFO John Markovich will host the call. Those wanting to access the…

MondayMar 18, 2024 10:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors

CNS Pharmaceuticals recently appointed Amy Mahery, a biotech commercialization leader, to its Board of Directors Ms. Mahery brings over 20 years’ experience, having worked with small and large companies, and has held diverse commercial leadership roles in the U.S. and globally The company believes Ms. Mahery’s guidance, insight, and vast pharma industry network will indeed be invaluable as the company advances Berubicin, its flagship drug candidate, toward completion of its global potentially pivotal clinical trial and potential regulatory approval The company recently completed the enrollment of patients in its potentially pivotal global clinical trial Ms. Mahery believes Berubicin represents an…

Site Search

Company Search

Month: March 2024